Skip to main content

Advertisement

SpringerLink
Log in

Reply to osteogenesis imperfecta calls for caution

  • Letters to the Editor
  • Published:

From Nature Medicine

View current issue Submit your manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Horwitz, E. M. et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med. 5, 309–313 ( 1999).

    Article  CAS  Google Scholar 

  2. Constantinou, C.D., Nielsen, K.B. & Prockop, D.J. A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cystine for glycine 904 of the alpha (I) chain of type I procollagen. J. Clin. Invest. 83 , 574–584 (1989).

    Article  CAS  Google Scholar 

  3. Wallis, G.A., Starman, B.J., Zinn, A.B. & Byers, P.H. Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1 (I) gene (COL1A1) of type I collagen in a parent. Am. J. Hum. Genet. 46, 1034–1040 (1990).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Edwards, M.J., Wenstrup, R.J., Byers, P.H. & Cohn, D.H. Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a mutation in the COL1A2 gene type I collagen. Hum. Mutat. 1, 47–54 (1992).

    Article  CAS  Google Scholar 

  5. Vetter, U. et.al . Osteogenesis Imperfecta: Changes in non-collagenous proteins in bone. J. Bone Miner. Res. 6, 501– 505 (1991).

    Article  CAS  Google Scholar 

  6. Mundlos, S. et al. Multiexon deletions in the type I collagen COL1A2 gene in Osteogenesis Imperfecta Type IB. J. Biol. Chem. 271 , 21068–21074 (1996).

    Article  CAS  Google Scholar 

  7. Koo, W.W.K., Bush, A.J., Walters, J., & Carlson, S.E. Postnatal development of bone mineral status during infancy. J. Amer. Coll. Nutr. 17, 65–70 (1998).

    Article  CAS  Google Scholar 

  8. Gerson, S.L. Mesenchymal stem cells: No longer second class citizens. Nature Med. 5, 262–263 ( 1999).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cell & Gene Therapy Program St. Jude Children's Research Hospital, 332 N. Lauderdale, Room D-4026, Memphis, 38101, Tennessee, USA

    Edwin M. Horwitz, Jeffrey C. Marx & Malcolm K. Brenner

  2. Allegheny University of the Health Sciences, 15th and Vine Streets, Philadelphia, 19102, Pennsylvania , USA

    Darwin J. Prockop

  3. Mayo Clinic, 200 First Street SW, Rochester, 55905, Minnesota, USA

    Lorraine A. Fitzpatrick

  4. Wayne State University, 4707 St. Antoine Boulevard, Detroit, 48201, Michigan, USA

    Winston W.K. Koo

Authors
  1. Edwin M. Horwitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Darwin J. Prockop
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorraine A. Fitzpatrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Winston W.K. Koo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeffrey C. Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Malcolm K. Brenner
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Horwitz, E., Prockop, D., Fitzpatrick, L. et al. Reply to osteogenesis imperfecta calls for caution. Nat Med 5, 466–467 (1999). https://doi.org/10.1038/8327

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/8327

  • Springer Nature America, Inc.

Search

Navigation